Daily oral etoposide in metastatic breast cancer

Anti-Cancer Drugs

Volumn 7, Issue 5, 1996, Pages 543-547

  Nešković Konstantinović, Zora B ^a   Bošnjak, Snežana M ^a   Radulović, Siniša S ^a   Mitrović, Labuda B ^a  

^a INSTITUTE FOR ONCOLOGY AND RADIOLOGY OF SERBIA   (Serbia)

Author keywords

advanced breast cancer; oral etoposide

Indexed keywords

CYCLOPHOSPHAMIDE; ETOPOSIDE; FLUOROURACIL; METHOTREXATE;

ALOPECIA; ANEMIA; ARTICLE; BREAST CANCER; CLINICAL ARTICLE; CLINICAL TRIAL; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; METASTASIS; NEUTROPENIA; ORAL DRUG ADMINISTRATION; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; THROMBOCYTOPENIA;

EID: 0029837372     PISSN: 09594973     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001813-199607000-00009     Document Type: Article

References (12)

1. Henwood JM, Brogden RN. Etoposide: a review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in combination chemotherapy of cancer. Drugs 1990; 39: 438-90.
2. Slevin ML, Clark PI, Joel SP, et al. A randomized trial to evaluate the effect of schedule on the activity of etoposide in small-cell lung cancer. J Clin Oncol 1989; 7: 1333-40.
3. Hainsworth JD, Johnson DH, Redlin Frazier S, Greco FA. Chronic daily administration of oral etoposide - a phase I trial. J Clin Oncol 1989; 7: 396-401.
4. Greco FA, Johnson DH, Hainsworth JD. Chronic daily administration of oral etoposide. Semin Oncol 1990; 17 (suppl 2): 71-4.
5. Einhorn LH, Pennington K, McClean J. Phase II trial of daily oral VP-16 in refractory small cell lung cancer: a Hoosier Oncology Group study. Semin Oncol 1990; 17 (suppl 2): 32-5.
6. Einhorn LH. Daily oral etoposide in the treatment of cancer. Semin Oncol 1991; 18 (suppl 2): 43-7.
7. Sessa C, Zucchetti M, Torri V, et al. Chronic oral etoposide in small-cell lung cancer: clinical and pharmacokinetic results. Ann Oncol 1993; 4: 553-8.
8. Wander HE, Rauschning W, Meyer D, Achterrath W, Nagel GA. Phase II study with Etoposide in previously untreated advanced breast cancer. Cancer Chemother Pharmacol 1989; 24: 261-3.
9. Calvert AH, Lind MJ, Millward MM, et al. Long-term oral etoposide in metastatic breast cancer: Clinical and pharmacokinetic results. Cancer Treat Rev 1993; 19 (suppl C): 27-33.
10. Martin M, Casado A, Lluch A, Adrover E, Diaz-Rubio E, Garcia-Conde J. Preliminary results of a phase II trial of chronic oral etoposide in breast cancer. Cancer Treat Rev 1993; 19 (suppl C): 47-52.
11. Hayward JL, Carbone PP, Heuson JC, et al. Assessment of response to therapy in advanced breast cancer. Cancer 1977; 39: 1289-94.
12. Hainsworth JD, Greco FA. Etoposide: twenty years later Ann Oncol 1995; 6: 325-41.